12 NF1 Germline and Somatic Mosaicism Ludwine Messiaen and Jing Xie 13 Deep Intronic NF1 Mutations and Possible Therapeutic Interventions...

Size: px
Start display at page:

Download "12 NF1 Germline and Somatic Mosaicism Ludwine Messiaen and Jing Xie 13 Deep Intronic NF1 Mutations and Possible Therapeutic Interventions..."

Transcription

1 Contents 1 von Recklinghausen Disease: 130 Years... 1 Vincent M. Riccardi 2 Clinical Diagnosis and Atypical Forms of NF Sirkku Peltonen and Minna Pöyhönen 3 Management and Treatment of Complex Neurofibromatosis Rosalie E. Ferner and Susan M. Huson 4 Mortality in Neurofibromatosis Gareth R. Evans 5 The Cognitive Profile of NF1 Children: Therapeutic Implications Natalie A. Pride and Kathryn N. North 6 Clinical Expression of NF1 in Monozygotic Twins Elizabeth K. Schorry and Emily Sites 7 Value of Whole Body MRI in Patients with NF Victor-Felix Mautner 8 Quality of Life in NF Patricia Birch and J.M. Friedman 9 NF1 Gene: Promoter, 5 0 UTR, and 3 0 UTR Hua Li and Margaret R. Wallace 10 The Germline Mutational Spectrum in Neurofibromatosis Type 1 and Genotype Phenotype Correlations David N. Cooper and Meena Upadhyaya 11 Splicing Mechanisms and Mutations in the NF1 Gene Marco Baralle and Diana Baralle xiii

2 xiv Contents 12 NF1 Germline and Somatic Mosaicism Ludwine Messiaen and Jing Xie 13 Deep Intronic NF1 Mutations and Possible Therapeutic Interventions Conxi Lázaro, Juana Fernández-Rodríguez, and Eduard Serra 14 NF1 Microdeletions and Their Underlying Mutational Mechanisms Hildegard Kehrer-Sawatzki and David N. Cooper 15 The Somatic Mutational Spectrum of the NF1 Gene Meena Upadhyaya, Nadia Chuzhanova, and David N. Cooper 16 Relationship Between NF1 and Constitutive Mismatch Repair Deficiency Katharina Wimmer 17 Insights into NF1 from Evolution Britta Bartelt-Kirbach and Dieter Kaufmann 18 Modifier Genes in NF Eric Pasmant, Dominique Vidaud, and Pierre Wolkenstein 19 Dissection of Complex Genetic and Epigenetic Interactions Underlying NF1 Cancer Susceptibility Using Mouse Models Georgette N. Jones and Karlyne M. Reilly 20 Neurofibromin: Protein Domains and Functional Characteristics Klaus Scheffzek and Stefan Welti 21 Molecular Basis of Bone Abnormalities in NF David A. Stevenson and Florent Elefteriou 22 NF1-Associated Optic Glioma Anne C. Solga and David H. Gutmann 23 Molecular Basis of Cardiovascular Abnormalities in NF Brian K. Stansfield, David A. Ingram, Simon J. Conway, and Jan M. Friedman 24 Molecular Basis of Glomus Tumours Hilde Brems, Eric Legius, and Douglas R. Stewart 25 Pheochromocytoma and NF Birke Bausch and Hartmut P.H. Neumann 26 Molecular and Cellular Basis of Human Cutaneous Neurofibromas and Their Development Juha Peltonen, Eeva-Mari Jouhilahti, and Sirkku Peltonen

3 Contents xv 27 Somatic Copy Number Alterations: Gene and Protein Expression Correlates in NF1-Associated Malignant Peripheral Nerve Sheath Tumors Meena Upadhyaya and David N. Cooper 28 Pathologic and Molecular Diagnostic Features of Peripheral Nerve Sheath Tumors in NF Anat Stemmer-Rachamimov and G. Petur Nielsen 29 Malignant Peripheral Nerve Sheath Tumors: Prognostic and Diagnostic Markers and Therapeutic Targets Holly Meany, Brigitte C. Widemann, and Nancy Ratner 30 NF1 Mutations in Hematologic Cancers Tiffany Chang and Kevin Shannon 31 Legius Syndrome: Diagnosis and Pathology Hilde Brems, Ludwine Messiaen, and Eric Legius 32 The RASopathies: Syndromes of Ras/MAPK Pathway Dysregulation William E. Tidyman and Katherine A. Rauen 33 Advances in NF1 Animal Models and Lessons Learned Ophélia Maertens and Karen Cichowski 34 Drosophila: An Invertebrate Model of NF James A. Walker, Jean Y. Gouzi, and André Bernards 35 Zebrafish Model for NF Arun Padmanabhan and Jonathan A. Epstein 36 Cell of Origin and the Contribution of Microenvironment in NF1 Tumorigenesis and Therapeutic Implications Johanna Buchstaller, D. Wade Clapp, Luis F. Parada, and Yuan Zhu 37 Molecular and Cellular Approaches to Cognitive Impairments Associated with NF1 and Other Rasopathies Yong-Seok Lee and Alcino J. Silva 38 Ras Signaling Pathway in Biology and Therapy of Malignant Peripheral Nerve Sheath Tumors Faris Farassati 39 MicroRNA and NF1 Tumorigenesis Adrienne M. Flanagan and Nadège Presneau 40 Translational/Clinical Studies in Children and Adults with Neurofibromatosis Type Bruce Korf, Brigitte Widemann, Maria T. Acosta, and Roger J. Packer

4 xvi Contents 41 The Role of NF1 Lay Foundations: Future Vision Kim Hunter-Schaedle 42 Social Stigma in Neurofibromatosis Joan Ablon 43 Personalized Medicine in NF David Viskochil 44 Neurofibromatosis Type 1: Future Directions (Where Do We Go from Here?) Luis F. Parada Index

5

PRELIMINARY PROGRAM (as per 24 April 2018)

PRELIMINARY PROGRAM (as per 24 April 2018) PRELIMINARY PROGRAM (as per 24 April 2018) FRIDAY - 2 NOVEMBER 2018 13:30-15:30 EDUCATIONAL SYMPOSIUM (Part 1) Clinical Dusica Babovic-Vuksanovic, MD Mimi Berman, MD Karin Cunha, PhD 13:30-15:30 ANIMAL

More information

PROGRAM (as of September 2018)

PROGRAM (as of September 2018) PROGRAM (as of September 2018) FRIDAY - 2 NOVEMBER 2018 08:30-12:30 OPTIONAL SATELLITE SYMPOSIUM Developing Therapeutics for Cutaneous Neurofibromas Sponsored by the Neurofibromatosis Therapeutics Acceleration

More information

Neurofibroma / Nerve Sheath Tumor

Neurofibroma / Nerve Sheath Tumor Dermal 95% Neurofibroma / Nerve Sheath Tumor Plexiform (PN) 25-40% Atypical (ANF) Unknown? MPNST 15.8% Appearance, pruritus Appearance, pain, function loss, Malignant transformation Loss of NF1 + CDKN2A/B

More information

Neurofibromatosis 1 (NF1) is an autosomal-dominant

Neurofibromatosis 1 (NF1) is an autosomal-dominant Neuro-Oncology Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1 Victor-F. Mautner, Florence A. Asuagbor, Eva Dombi, Carsten Fünsterer, Lan Kluwe, Ralf Wenzel, Brigitte

More information

Mini-Review. The Pathoetiology of Neurofibromatosis 1. Genetic Background. Neurofibromatosis 1 as a Clinical Entity

Mini-Review. The Pathoetiology of Neurofibromatosis 1. Genetic Background. Neurofibromatosis 1 as a Clinical Entity Mini-Review The American Journal of Pathology, Vol. 178, No. 5, May 2011 Copyright 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved. DOI: 10.1016/j.ajpath.2010.12.056

More information

V. Neurofibromatosis Research Program

V. Neurofibromatosis Research Program V. Neurofibromatosis Program Vision: To decrease the impact of neurofibromatosis. Mission: To promote research directed toward the understanding, diagnosis, and treatment of NF1 and NF2 and to enhance

More information

Clinical presentations of 23 half-siblings from a mosaic neurofibromatosis type 1 sperm donor

Clinical presentations of 23 half-siblings from a mosaic neurofibromatosis type 1 sperm donor Clin Genet 2016: 89: 346 350 Printed in Singapore. All rights reserved Short Report 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd CLINICAL GENETICS doi: 10.1111/cge.12600 Clinical presentations

More information

Neurofibromatosis, type 1. Fawn Leigh, M.D.

Neurofibromatosis, type 1. Fawn Leigh, M.D. Neurofibromatosis, type 1 Fawn Leigh, M.D. Neurofibromatosis Types Neurofibromatosis type 1 1 in 3,000 Neurofibromatosis type 2 1 in 25,000 Schwannomatosis 1 in 40,000 Neurofibromatosis, type 1 Incidence

More information

Mechanisms of Loss of Heterozygosity in Neurofibromatosis Type 1-Associated Plexiform Neurofibromas

Mechanisms of Loss of Heterozygosity in Neurofibromatosis Type 1-Associated Plexiform Neurofibromas ORIGINAL ARTICLE Mechanisms of Loss of Heterozygosity in Neurofibromatosis Type 1-Associated Plexiform Neurofibromas Katharina Steinmann 1, Lan Kluwe 2, Reinhard E. Friedrich 2, Victor-Felix Mautner 2,

More information

NF1 Mutations and Clinical Manifestations in Neurofibromatosis Type 1 Patients in Tamil Nadu, South India

NF1 Mutations and Clinical Manifestations in Neurofibromatosis Type 1 Patients in Tamil Nadu, South India International Research Journal of Biological Sciences E-ISSN 2278-3202 Vol. 5(8), 38-44, August (2016) NF1 Mutations and linical Manifestations in Neurofibromatosis Type 1 Patients in Tamil Nadu, South

More information

Neurofibromatosis type 1: from genotype to phenotype

Neurofibromatosis type 1: from genotype to phenotype 1 UMR745 INSERM, Université Paris Descartes, Sorbonne Paris Cité, Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France 2 Service de Biochimie et de Génétique Moléculaire, Hôpital Cochin,

More information

Influence of Learning Disabilities on the Tumour Predisposition Syndrome NF1 Survey from Adult Patients Perspective

Influence of Learning Disabilities on the Tumour Predisposition Syndrome NF1 Survey from Adult Patients Perspective Influence of Learning Disabilities on the Tumour Predisposition Syndrome NF1 Survey from Adult Patients Perspective SOFIA GRANSTRÖM 1, REINHARD E. FRIEDRICH 2,3, ANNA KATHARINA LANGENBRUCH 4, MATTHIAS

More information

Neurofibromatosis type 1-associated tumours: Their somatic mutational spectrum and pathogenesis

Neurofibromatosis type 1-associated tumours: Their somatic mutational spectrum and pathogenesis REVIEW Neurofibromatosis type 1-associated tumours: Their somatic al spectrum and pathogenesis Sebastian Laycock-van Spyk, Nick Thomas, David N. Cooper and Meena Upadhyaya * Institute of Medical Genetics,

More information

Constitutional NF1 Mutations In Neurofibromatosis 1 Patients With Malignant Peripheral Nerve Sheath Tumors

Constitutional NF1 Mutations In Neurofibromatosis 1 Patients With Malignant Peripheral Nerve Sheath Tumors HUMAN MUTATION Mutation in Brief #664 (2003) Online MUTATION IN BRIEF Constitutional NF1 Mutations In Neurofibromatosis 1 Patients With Malignant Peripheral Nerve Sheath Tumors Lan Kluwe 1 *, Reinhard

More information

Phenotype GenotypeCorrelationinChildren with Neurofibromatosis Type 1

Phenotype GenotypeCorrelationinChildren with Neurofibromatosis Type 1 Original Article Phenotype GenotypeCorrelationinChildren with Neurofibromatosis Type 1 Christophe Barrea 1 Sandrine Vaessen 1 Saskia Bulk 2 Julie Harvengt 2 Jean-Paul Misson 1 1 Department of Pediatrics,

More information

Clinical characterization of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions

Clinical characterization of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions Clinical characterization of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions Victor-Felix Mautner, Lan Kluwe, Angelika C. Roehl, Simmone Bammert, David N Cooper,

More information

Technical Advance. Detection and Characterization of NF1 Microdeletions by Custom High Resolution Array CGH

Technical Advance. Detection and Characterization of NF1 Microdeletions by Custom High Resolution Array CGH Technical Advance Journal of Molecular Diagnostics, Vol. 11, No. 6, November 2009 Copyright American Society for Investigative Pathology and the Association for Molecular Pathology DOI: 10.2353/jmoldx.2009.090064

More information

Neurofibromatosis type 1 and RASopathies

Neurofibromatosis type 1 and RASopathies Neurofibromatosis type 1 and RASopathies Dawn Siegel, MD Medical College of Wisconsin American Academy of Dermatology San Diego, CA February 19 th, 2018 Neurofibromatosis Type 1 NF1- diagnostic criteria

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Genetic Testing for Neurofibromatosis File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_neurofibromatosis 4/2016 7/2017 7/2018 1/2018 Description

More information

Neurofibromatosis type 1 and malignancy in childhood

Neurofibromatosis type 1 and malignancy in childhood Clin Genet 2016: 89: 341 345 Printed in Singapore. All rights reserved Short Report 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd CLINICAL GENETICS doi: 10.1111/cge.12625 Neurofibromatosis

More information

N eurofibromatosis type 1 (NF1) is an autosomal

N eurofibromatosis type 1 (NF1) is an autosomal 1of5 ELECTRONIC LETTER Evaluation of genotype-phenotype correlations in neurofibromatosis type 1 B Castle, M E Baser, S M Huson, D N Cooper, M Upadhyaya... N eurofibromatosis type 1 (NF1) is an autosomal

More information

REBECCA L. LODA-HUTCHINSON

REBECCA L. LODA-HUTCHINSON ANALYSIS OF NF1 MUTATION MECHANISMS By REBECCA L. LODA-HUTCHINSON A DISSERTATION PRESENTED TO THE GRADUATE SCHOOL OF THE UNIVERSITY OF FLORIDA IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE

More information

Polyclonal rabbit anti-neurofibromin: PcNFn27, Monoclonal rabbit antineurofibromin:

Polyclonal rabbit anti-neurofibromin: PcNFn27, Monoclonal rabbit antineurofibromin: Project title/type PI/contact Tool category Tool Description/Features Tool Status Publications Funded by NTAP Ras Reference Reagents Initiative Dominic Esposito Reagent Collection of entry clones (both

More information

Estratègies terapèutiques per la Neurofibromatosi de tipus 1

Estratègies terapèutiques per la Neurofibromatosi de tipus 1 Estratègies terapèutiques per la Neurofibromatosi de tipus 1 Joan Castellsagué Garcia Aquesta tesi doctoral està subjecta a la llicència Reconeixement 3.0. Espanya de Creative Commons. Esta tesis doctoral

More information

MEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG)

MEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG) Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG) Ordering Information Acceptable specimen types: Fresh blood sample (3-6 ml EDTA; no time limitations associated with receipt)

More information

TITLE: Genetic and Epigenetic Differences in Monozygotic Twins with NF1

TITLE: Genetic and Epigenetic Differences in Monozygotic Twins with NF1 AD AWARD NUMBER: W81XWH-10-1-0867 TITLE: Genetic and Epigenetic Differences in Monozygotic Twins with NF1 PRINCIPAL INVESTIGATOR: Elizabeth K. Schorry, M.D. CONTRACTING ORGANIZATION: Cincinnati Children's

More information

The Spectrum of NF1 Mutations in Korean Patients with Neurofibromatosis Type 1

The Spectrum of NF1 Mutations in Korean Patients with Neurofibromatosis Type 1 J Korean Med Sci 2006; 21: 107-12 ISSN 1011-8934 Copyright The Korean Academy of Medical Sciences The Spectrum of NF1 Mutations in Korean Patients with Neurofibromatosis Type 1 Neurofibromatosis type 1

More information

Non-optic glioma in adults and children with neurofibromatosis 1

Non-optic glioma in adults and children with neurofibromatosis 1 Sellmer et al. Orphanet Journal of Rare Diseases (2017) 12:34 DOI 10.1186/s13023-017-0588-2 RESEARCH Non-optic glioma in adults and children with neurofibromatosis 1 Laura Sellmer 1*, Said Farschtschi

More information

Neurofibromatosis 1 PRACTICAL GENETICS

Neurofibromatosis 1 PRACTICAL GENETICS (2007) 15, 131 138 & 2007 Nature Publishing Group All rights reserved 1018-4813/07 $30.00 www.nature.com/ejhg PRACTICAL GENETICS In association with predisposes affected individuals to the development

More information

Ne u r o f i b r o m at o s i s Type 1 is a common autosomal

Ne u r o f i b r o m at o s i s Type 1 is a common autosomal Neurosurg Focus 28 (1):E8, 2010 Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications Or e n N. Go t t f r i e d, M.D., 1 Dav i d H. Vi s k o c h i l, M.D., Ph.D.,

More information

PERSPECTIVES. Neurofibromatosis type 1 a model for nervous system tumour formation? Joshua B. Rubin and David H. Gutmann

PERSPECTIVES. Neurofibromatosis type 1 a model for nervous system tumour formation? Joshua B. Rubin and David H. Gutmann OPINION Neurofibromatosis type 1 a model for nervous system tumour formation? Joshua B. Rubin and David H. Gutmann Abstract Neurofibromatosis type 1 (NF1) is a common genetic condition in which affected

More information

126 novel mutations in Italian patients with neurofibromatosis type 1

126 novel mutations in Italian patients with neurofibromatosis type 1 ORIGINAL ARTICLE 126 novel mutations in Italian patients with neurofibromatosis type 1 Donatella Bianchessi 1,a, Sara Morosini 1,a, Veronica Saletti 2, Maria Cristina Ibba 1, Federica Natacci 3, Silvia

More information

Spinal Neurofibromatosis without Café-au-Lait Macules in Two Families with Null Mutations of the NF1 Gene

Spinal Neurofibromatosis without Café-au-Lait Macules in Two Families with Null Mutations of the NF1 Gene Am. J. Hum. Genet. 69:1395 1400, 2001 Report Spinal Neurofibromatosis without Café-au-Lait Macules in Two Families with Null Mutations of the NF1 Gene Dieter Kaufmann, 1 Ralf Müller, 1 Britta Bartelt,

More information

Current status and recommendations for biomarkers and biobanking in neurofibromatosis

Current status and recommendations for biomarkers and biobanking in neurofibromatosis Current status and recommendations for biomarkers and biobanking in neurofibromatosis C. Oliver Hanemann, MD, PhD Jaishri O. Blakeley, MD Fabio P. Nunes, MD, MMSc Kent Robertson, MD Anat Stemmer- Rachamimov,

More information

The neurofibromatoses: more than just a medical curiosity

The neurofibromatoses: more than just a medical curiosity PAPER 2006 Royal College of Physicians of Edinburgh The neurofibromatoses: more than just a medical curiosity SM Huson Honorary Consultant Clinical Geneticist, Regional Genetics Service, St Mary s Hospital,

More information

Neurofibromatosis 2 (NF2) is an autosomal dominant disease. Empirical development of improved diagnostic criteria for neurofibromatosis 2 ARTICLE

Neurofibromatosis 2 (NF2) is an autosomal dominant disease. Empirical development of improved diagnostic criteria for neurofibromatosis 2 ARTICLE ARTICLE Empirical development of improved diagnostic criteria for neurofibromatosis 2 Michael E. Baser, PhD 1, Jan M. Friedman, MD, PhD 2, Harry Joe, PhD 3, Andrew Shenton, BSc 4, Andrew J. Wallace, PhD

More information

MEDICAL GENOMICS LABORATORY. Peripheral Nerve Sheath Tumor Panel by Next-Gen Sequencing (PNT-NG)

MEDICAL GENOMICS LABORATORY. Peripheral Nerve Sheath Tumor Panel by Next-Gen Sequencing (PNT-NG) Peripheral Nerve Sheath Tumor Panel by Next-Gen Sequencing (PNT-NG) Ordering Information Acceptable specimen types: Blood (3-6ml EDTA; no time limitations associated with receipt) Saliva (OGR-575 DNA Genotek;

More information

A search for evidence of somatic mutations in the NF1 gene

A search for evidence of somatic mutations in the NF1 gene 44 Institute of Medical Genetics, University College of Medicine of Wales, Heath Park, CardiV CF4 4XN, UK AMJohn M Upadhyaya Department of Paediatric Neurology, Paediatric Clinic, University of Catania,

More information

The epigenetic differences between. neurofibromas and malignant peripheral nerve. sheath tumours

The epigenetic differences between. neurofibromas and malignant peripheral nerve. sheath tumours Page 1 The epigenetic differences between neurofibromas and malignant peripheral nerve sheath tumours A thesis submitted to the University College London (UCL) for the degree of Doctor of Philosophy By

More information

Update on Genetic Testing for Melanoma

Update on Genetic Testing for Melanoma Update on Genetic Testing for Melanoma Emily Y. Chu, M.D., Ph.D. Assistant Professor of Dermatology & Pathology and Laboratory Medicine Hospital of the University of Pennsylvania February 18, 2018 AAD

More information

JMG Online First, published on June 28, 2013 as /jmedgenet Genotype-phenotype correlations

JMG Online First, published on June 28, 2013 as /jmedgenet Genotype-phenotype correlations JMG Online First, published on June 28, 2013 as 10.1136/jmedgenet-2013-101648 Genotype-phenotype correlations 1 Genetic Medicine Research Group, Faculty of Medical and Human Sciences, Institute of Human

More information

To cite this version: HAL Id: hal https://hal.archives-ouvertes.fr/hal

To cite this version: HAL Id: hal https://hal.archives-ouvertes.fr/hal Cranial meningiomas in 411 NF2 patients with proven gene mutations: Clear positional effect of mutations, but absence of female severity effect on age at onset Miriam Jane Smith, Jenny E Higgs, Naomi L

More information

STUDY. Pierre Wolkenstein, MD, PhD; Jacques Zeller, MD; Jean Revuz, MD; Emmanuel Ecosse, PhD; Alain Leplège, MD, PhD

STUDY. Pierre Wolkenstein, MD, PhD; Jacques Zeller, MD; Jean Revuz, MD; Emmanuel Ecosse, PhD; Alain Leplège, MD, PhD Quality-of-Life Impairment in Neurofibromatosis Type 1 A Cross-sectional Study of 128 Cases STUDY Pierre Wolkenstein, MD, PhD; Jacques Zeller, MD; Jean Revuz, MD; Emmanuel Ecosse, PhD; Alain Leplège, MD,

More information

Plexiform Tumor of the Orbit

Plexiform Tumor of the Orbit Plexiform Tumor of the Orbit Anat Stemmer-Rachamimov, MD Department of Pathology Massachusetts General Hospital Harvard Medical School Disclosure of Relevant Financial Relationships USCAP requires that

More information

Recent developments in neurofibromatosis type 1 Ming-Jen Lee a and Dennis A. Stephenson b

Recent developments in neurofibromatosis type 1 Ming-Jen Lee a and Dennis A. Stephenson b Recent developments in neurofibromatosis type 1 Ming-Jen Lee a and Dennis A. Stephenson b Purpose of review This review summarizes the recent clinical and genetic developments in neurofibromatosis type

More information

Developing therapies for Ras-driven tumors

Developing therapies for Ras-driven tumors Developing therapies for Ras-driven tumors Karen Cichowski, Ph.D. Harvard Medical School Ludwig Center at HMS Brigham and Women s Hospital Dana Farber/Harvard Cancer Center Disclosures: Genentech (Consultant)

More information

A Novel Deep Intronic Mutation Introducing a Cryptic Exon Causing Neurofibromatosis Type 1 in a Family with Highly Variable Phenotypes: A Case Study

A Novel Deep Intronic Mutation Introducing a Cryptic Exon Causing Neurofibromatosis Type 1 in a Family with Highly Variable Phenotypes: A Case Study ics: Current Research ISSN: 2161-1041 ics Svaasand et al., 2015, 4:3 DOI: 10.4172/2161- Case Report Open Access A Novel Deep Intronic Mutation Introducing a Cryptic Exon Causing Neurofibromatosis Type

More information

Perioperative Management of Neurofibromatosis Type 1

Perioperative Management of Neurofibromatosis Type 1 The Ochsner Journal 12:111 121, 2012 Ó Academic Division of Ochsner Clinic Foundation Perioperative Management of Neurofibromatosis Type 1 Charles J. Fox, MD,* Samir Tomajian, MD,* Aaron J. Kaye, à Stephanie

More information

A Storyboard Approach to Charting Research Progress and Demonstrating Impact. Naba Bora, Ph.D. The Congressionally Directed Medical Research Programs

A Storyboard Approach to Charting Research Progress and Demonstrating Impact. Naba Bora, Ph.D. The Congressionally Directed Medical Research Programs The Congressionally Directed Medical Research Programs A Storyboard Approach to Charting Research Progress and Demonstrating Impact Naba Bora, Ph.D. Program Manager The views expressed in this presentation

More information

Role of Health Visitors in identifying signs of Neurofibromatosis type 1 (NF1)?

Role of Health Visitors in identifying signs of Neurofibromatosis type 1 (NF1)? Role of Health Visitors in identifying signs of Neurofibromatosis type 1 (NF1)? My name is Dr Carly Jim I am a Senior Lecturer at Manchester Metropolitan University (MMU) and one of the Trustees of the

More information

MEDICAL GENOMICS LABORATORY. Non-NF1 RASopathy panel by Next-Gen Sequencing and Deletion/Duplication Analysis of SPRED1 (NNP-NG)

MEDICAL GENOMICS LABORATORY. Non-NF1 RASopathy panel by Next-Gen Sequencing and Deletion/Duplication Analysis of SPRED1 (NNP-NG) Non-NF1 RASopathy panel by Next-Gen Sequencing and Deletion/Duplication Analysis of SPRED1 (NNP-NG) Ordering Information Acceptable specimen types: Blood (3-6ml EDTA; no time limitations associated with

More information

Case Report Familial Lymphoproliferative Malignancies and Tandem Duplication of NF1 Gene

Case Report Familial Lymphoproliferative Malignancies and Tandem Duplication of NF1 Gene Case Reports in Oncological Medicine, Article ID 685857, 4 pages http://dx.doi.org/10.1155/2014/685857 Case Report Familial Lymphoproliferative Malignancies and Tandem Duplication of NF1 Gene Gustavo Fernandes,

More information

Health Supervision for Children With Neurofibromatosis

Health Supervision for Children With Neurofibromatosis CLINICAL REPORT Health Supervision for Children With Neurofibromatosis Guidance for the Clinician in Rendering Pediatric Care Joseph H. Hersh, MD, and the Committee on Genetics ABSTRACT Neurofibromatosis

More information

TITLE: Tibial Bowing and Pseudarthrosis in Neurofibromatosis Type 1

TITLE: Tibial Bowing and Pseudarthrosis in Neurofibromatosis Type 1 AWARD NUMBER: W81XWH-11-1-25 TITLE: Tibial Bowing and Pseudarthrosis in Neurofibromatosis Type 1 PRINCIPAL INVESTIGATOR: Dr. David Stevenson CONTRACTING ORGANIZATION: University of Utah SALT LAKE CITY,

More information

Introduction. Overview

Introduction. Overview Neurofibromatosis type 1 Wendy Sherman MD (Dr. Sherman of Feinberg School of Medicine at Northwestern University in Chicago, Illinois, has no relevant financial relationships to disclose.) Jeffrey J Raizer

More information

Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification

Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification 800 MUTATION REPORT Deletions of NF1 gene and exons detected by multiplex ligation-dependent probe amplification A De Luca, I Bottillo, M C Dasdia, A Morella, V Lanari, L Bernardini, L Divona, S Giustini,

More information

Mortality associated with neurofibromatosis type 1: A study based on Italian death certificates ( )

Mortality associated with neurofibromatosis type 1: A study based on Italian death certificates ( ) RESEARCH Open Access Mortality associated with neurofibromatosis type 1: A study based on Italian death certificates (1995-2006) Maria Masocco 1*, Yllka Kodra 2, Monica Vichi 1, Susanna Conti 1, Mark Kanieff

More information

Case Report A Very Rare Assocıatıon; Coexıstence of Breast Cancer, Pheochromocytoma and Neurofıbromatosıs Type 1 in a Female Patıent

Case Report A Very Rare Assocıatıon; Coexıstence of Breast Cancer, Pheochromocytoma and Neurofıbromatosıs Type 1 in a Female Patıent IBIMA Publishing International Journal of Case Reports in Medicine http://www.ibimapublishing.com/journals/ijcrm/ijcrm.html Vol. 2013 (2013), Article ID 511990, 6 pages DOI: 10.5171/2013.511990 Case Report

More information

D escriptions of individuals purported to have. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1 REVIEW

D escriptions of individuals purported to have. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1 REVIEW 81 REVIEW Guidelines for the diagnosis and management of individuals with neurofibromatosis 1 Rosalie E Ferner, Susan M Huson, Nick Thomas, Celia Moss, Harry Willshaw, D Gareth Evans, Meena Upadhyaya,

More information

Gamsızkan M, Kantarcıoglu CS, Yılmaz I, Yalcinkaya U, Sungur MA, Buyucek S, Onal B

Gamsızkan M, Kantarcıoglu CS, Yılmaz I, Yalcinkaya U, Sungur MA, Buyucek S, Onal B Tykhe, from Konuralp/Duzce TERT promoter mutation and HER2 gene amplification in malignant peripheral nerve sheath tumours: is there a molecular signature playing role in malignant transformation? Gamsızkan

More information

NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype

NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype NF microdeletions in neurofibromatosis type : from genotype to phenotype Eric Pasmant, Audrey Sabbagh, Gill Spurlock, Ingrid Laurendeau, Elisa Grillo, Marie-Josée Hamel, Ludovic Martin, Sébastien Barbarot,

More information

NEUROFIBROMATOSIS TYPE 1: FROM GENE TO POPULATION AND CANCER. Elina Uusitalo

NEUROFIBROMATOSIS TYPE 1: FROM GENE TO POPULATION AND CANCER. Elina Uusitalo NEUROFIBROMATOSIS TYPE 1: FROM GENE TO POPULATION AND CANCER Elina Uusitalo TURUN YLIOPISTON JULKAISUJA ANNALES UNIVERSITATIS TURKUENSIS Sarja - ser. D osa - tom. 1339 Medica - Odontologica Turku 2018

More information

NF1 Microdeletions in Neurofibromatosis Type 1: From Genotype to Phenotype

NF1 Microdeletions in Neurofibromatosis Type 1: From Genotype to Phenotype HUMAN MUTATION Mutation in Brief 31: E1506-E1516 (2010) Online MUTATION IN BRIEF NF1 Microdeletions in Neurofibromatosis Type 1: From Genotype to Phenotype HUMAN MUTATION OFFICIAL JOURNAL www.hgvs.org

More information

Studying The Role Of DNA Mismatch Repair In Brain Cancer Malignancy

Studying The Role Of DNA Mismatch Repair In Brain Cancer Malignancy Kavya Puchhalapalli CALS Honors Project Report Spring 2017 Studying The Role Of DNA Mismatch Repair In Brain Cancer Malignancy Abstract Malignant brain tumors including medulloblastomas and primitive neuroectodermal

More information

V. Neurofibromatosis Research Program

V. Neurofibromatosis Research Program V. Neurofibromatosis Research Program advancing laboratory research to the clinic Vision: To decrease the impact of neurofibromatosis and schwannomatosis. Mission: To promote research directed toward the

More information

Int J Clin Exp Pathol 2015;8(5): /ISSN: /IJCEP Shogo Tajima 1, Kenji Koda 2

Int J Clin Exp Pathol 2015;8(5): /ISSN: /IJCEP Shogo Tajima 1, Kenji Koda 2 Int J Clin Exp Pathol 2015;8(5):5113-5120 www.ijcep.com /ISSN:1936-2625/IJCEP0007009 Original Article A neurogenic tumor containing a low-grade malignant peripheral nerve sheath tumor (MPNST) component

More information

A prospective study of neurofibromatosis type 1 cancer incidence in the UK

A prospective study of neurofibromatosis type 1 cancer incidence in the UK British Journal of Cancer (2006) 95, 233 238 All rights reserved 0007 0920/06 $30.00 www.bjcancer.com A prospective study of neurofibromatosis type 1 cancer incidence in the UK L Walker 1, D Thompson 2,

More information

Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1

Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1 Corsello et al. Italian Journal of Pediatrics (2018) 44:45 https://doi.org/10.1186/s13052-018-0483-z RESEARCH Open Access Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis

More information

Neurofibromatosis (NF) Center

Neurofibromatosis (NF) Center Washington University Neurofibromatosis (NF) Center THE NF CENTER: EXCEPTIONAL CARE THROUGH GROUNDBREAKING RESEARCH An international leader in research and treatment of neurofibromatosis (NF), the Washington

More information

MRC-Holland MLPA. Description version 30; 06 June 2017

MRC-Holland MLPA. Description version 30; 06 June 2017 SALSA MLPA probemix P081-C1/P082-C1 NF1 P081 Lot C1-0517, C1-0114. As compared to the previous B2 version (lot B2-0813, B2-0912), 11 target probes are replaced or added, and 10 new reference probes are

More information

Neurofibromatosis 1 Prevalence in Children Aged 9 11 Years, Pinar del Río Province, Cuba

Neurofibromatosis 1 Prevalence in Children Aged 9 11 Years, Pinar del Río Province, Cuba Neurofibromatosis 1 Prevalence in Children Aged 9 11 Years, Pinar del Río Province, Cuba Miladys Orraca MD PhD, Griselda Morejón MS, Niurka Cabrera MS, Reinaldo Menéndez MD MS, Odalys Orraca MD MS ABSTRACT

More information

Comprehensive Testing for neurofibromatoses, RASopathies, and tuberous sclerosis at UAB

Comprehensive Testing for neurofibromatoses, RASopathies, and tuberous sclerosis at UAB Medical Genomics Laboratory Department of Genetics Noonan syndrome/nsml Costello syndrome Cardio-facio-cutaneous syndrome Neurofibromatosis type 1 Legius syndrome Comprehensive Testing for neurofibromatoses,

More information

Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions

Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions Mußotter et al. BMC Medical Genetics 2012, 13:98 RESEARCH ARTICLE Non-coding RNA ANRIL and the number of plexiform neurofibromas in patients with NF1 microdeletions Tanja Mußotter 1, Lan Kluwe 2,3, Josef

More information

MRC-Holland MLPA. Description version 29; 31 July 2015

MRC-Holland MLPA. Description version 29; 31 July 2015 SALSA MLPA probemix P081-C1/P082-C1 NF1 P081 Lot C1-0114. As compared to the previous B2 version (lot 0813 and 0912), 11 target probes are replaced or added, and 10 new reference probes are included. P082

More information

Neurological complications of neurofibromatosis type 1 in adulthood

Neurological complications of neurofibromatosis type 1 in adulthood Brain (1999), 122, 473 481 Neurological complications of neurofibromatosis type 1 in adulthood A. Créange, 1,2,6 J. Zeller, 2,3 S. Rostaing-Rigattieri, 2,4 P. Brugières, 2,5 J.-D. Degos, 1 J. Revuz 3 and

More information

Epidermal growth factor receptor expression in neurofibromatosis type 1 related tumors and NF1 animal models

Epidermal growth factor receptor expression in neurofibromatosis type 1 related tumors and NF1 animal models Epidermal growth factor receptor expression in neurofibromatosis type 1 related tumors and NF1 animal models Jeffrey E. DeClue, 1 Sue Heffelfinger, 2 Giovanna Benvenuto, 1 Bo Ling, 3 Shaowei Li, 1 Wen

More information

Imaging in neurofibromatosis type 1: An original research article with focus on spinal lesions

Imaging in neurofibromatosis type 1: An original research article with focus on spinal lesions Original Research Article Imaging in neurofibromatosis type 1: An original research article with focus on spinal lesions Kalpesh Patel 1*, Siddharth Zala 2, C. Raychaudhuri 3 1 Assistant Professor, 2 1

More information

Growth in North American white children with neurofibromatosis 1 (NF1)

Growth in North American white children with neurofibromatosis 1 (NF1) J Med Genet 2000;37:933 938 933 Department of Medical Genetics, The University of British Columbia, 222-6174 University Boulevard, Vancouver, BC V6T 1Z3, Canada J Szudek P Birch J M Friedman Correspondence

More information

Neurofibromatosis Network Advocacy Program. NF Network Advocacy Program. Structure your Congressional meeting

Neurofibromatosis Network Advocacy Program. NF Network Advocacy Program. Structure your Congressional meeting Neurofibromatosis Network Advocacy Program NF Network Advocacy Program Structure your Congressional meeting Structure Your Congressional Meeting Introduction & Thank you Explain NF Impact Personal Story

More information

MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors

MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors Walter J. Jessen,, Timothy P. Cripe, Nancy Ratner J Clin Invest. 2013;123(1):340-347. https://doi.org/10.1172/jci60578. Research

More information

MRC-Holland MLPA. Description version 08; 18 November 2016

MRC-Holland MLPA. Description version 08; 18 November 2016 SALSA MLPA probemix P122-D1 NF1 AREA Lot D1-1016. As compared to lot C2-0312, four probes in the NF1 area and one reference probe have been removed, four reference probes have been replaced and several

More information

World Journal of Colorectal Surgery

World Journal of Colorectal Surgery World Journal of Colorectal Surgery Volume 3, Issue 2 2013 Article 16 Neurofibroma of the anorectal canal presenting with diarrhoea and pelvic pain: Report a Case Waheeb Radman Al-Kubati Leila Ghaharamani

More information

Living with Neurofibromatosis Type 1: A Guide for Adults

Living with Neurofibromatosis Type 1: A Guide for Adults Living with Neurofibromatosis Type 1: A Guide for Adults by Linda Piersall, M.S. David H. Gutmann, M.D., Ph.D. Neurofibromatosis Program St. Louis Children s Hospital St. Louis, Missouri Rosalie Ferner,

More information

TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions

TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions ONCOLOGY REPORTS 32: 1347-1354, 2014 TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions Gun-Hoo Park 1,2*,

More information

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS

Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS Comprehensive Testing for Constitutional/Mosaic Mutations with Deep Coverage via NGS NF1/SPRED1 and Other RASopathy Related Conditions NF1 only NGS testing and copy number analysis for the NF1 gene (NF1

More information

INTERNATIONAL SYMPOSIUM ON NEW DEVELOPMENTS IN NEUROFIBROMATOSES AND RASOPATHIES

INTERNATIONAL SYMPOSIUM ON NEW DEVELOPMENTS IN NEUROFIBROMATOSES AND RASOPATHIES INTERNATIONAL SYMPOSIUM ON NEW DEVELOPMENTS IN NEUROFIBROMATOSES AND RASOPATHIES Their Management, Diagnosis, Current and Future Therapeutic Targets 27 th - 29 th November 2017, Crowne Plaza, Kochi, Kerala,

More information

Background Principles and Technical Development

Background Principles and Technical Development Contents Part I Background Principles and Technical Development 1 Introduction and the Nature of Radiosurgery... 3 Definitions of Radiosurgery... 5 Consequences of Changing Definitions of Radiosurgery...

More information

Spindle Cell Carcinoma: A Rare Malignant Transformation in Neurofibromatosis (NF1): A Case Study

Spindle Cell Carcinoma: A Rare Malignant Transformation in Neurofibromatosis (NF1): A Case Study JMSCR Volume 2 Issue 6 Page 1294-1298 June www.jmscr.igmpublication.org Impact Factor 1.1147 ISSN (e)-2347-176x Abstract Spindle Cell Carcinoma: A Rare Malignant Transformation in Neurofibromatosis (NF1):

More information

New insights in the molecular pathogenesis of neurofibromatosis type 1. Ophélia Maertens

New insights in the molecular pathogenesis of neurofibromatosis type 1. Ophélia Maertens New insights in the molecular pathogenesis of neurofibromatosis type 1 Ophélia Maertens Ghent University, Faculty of Medicine and Health Sciences Center for Medical Genetics New insights in the molecular

More information

Carcinogenesis. Carcinogenesis. 1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples

Carcinogenesis. Carcinogenesis. 1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples Carcinogenesis 1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples Major Principles (cont d) 4. Principle targets of genetic damage: 4 classes

More information

Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation- Dependent Probe Amplification analysis

Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation- Dependent Probe Amplification analysis Wu-Chou et al. Journal of Biomedical Science (2018) 25:72 https://doi.org/10.1186/s12929-018-0474-9 RESEARCH Open Access Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing

More information

The Neurofibromatoses. Part 2: NF2 and Schwannomatosis

The Neurofibromatoses. Part 2: NF2 and Schwannomatosis DIAGNOSIS AND TREATMENT REVIEW The Neurofibromatoses. Part 2: NF2 and Schwannomatosis Christine Lu-Emerson, MD,* Scott R. Plotkin, MD, PhD *Department of Neurology, University of Washington, Seattle, WA;

More information

Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1

Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1 Thomas et al. Human Genomics 2012, 6:18 PRIMARY RESEARCH Open Access Molecular heterogeneity in malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1 Laura Thomas 1, Victor-Felix

More information

Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study

Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study Cannon et al. Orphanet Journal of Rare Diseases (2018) 13:31 https://doi.org/10.1186/s13023-018-0772-z RESEARCH Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study

More information

Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more

Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more 450 Med Genet 98;:450-455 Department of Medical Genetics, St Mary's Hospital, Manchester M13 OJH, UK D G R Evans A Wallace University Department of Human Genetics, Newcastle University, Newcastle upon

More information

1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples. Major Principles:

1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples. Major Principles: Carcinogenesis 1. Basic principles 2. 6 hallmark features 3. Abnormal cell proliferation: mechanisms 4. Carcinogens: examples Carcinogenesis Major Principles: 1. Nonlethal genetic damage is central to

More information

U University. The Cognitive Dysfunction and Skeletal Dysplasias of NF1: Are We Ready for Clinical Trials? Neurofibromatosis Type 1

U University. The Cognitive Dysfunction and Skeletal Dysplasias of NF1: Are We Ready for Clinical Trials? Neurofibromatosis Type 1 The Cognitive Dysfunction and Skeletal Dysplasias of NF1: Are We Ready for Clinical Trials? John C. Carey Division of Medical Genetics, Department of Pediatrics U University of Utah Genetics and Wiley

More information

Multiple tumours of peripheral nerves are often

Multiple tumours of peripheral nerves are often Multiple schwannomas in the peripheral nerves Akira Ogose, Tetsuo Hotta, Tetsuro Morita, Hiroshi Otsuka, Yasuharu Hirata From Niigata Cancer Centre Hospital and Niigata University, Japan Multiple tumours

More information

RESEARCH ARTICLE. Human Mutation

RESEARCH ARTICLE. Human Mutation RESEARCH ARTICLE Human Mutation OFFICIAL JOURNAL Dissecting Loss of Heterozygosity (LOH) in Neurofibromatosis Type 1-Associated Neurofibromas: Importance of Copy Neutral LOH www.hgvs.org Carles Garcia-Linares,

More information

NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors

NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors INTERNATIONAL JOURNAL OF ONCOLOGY 42: 657-666, 2013 NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors

More information